PL100614B1 - Sposob wytwarzania nowych,eterowych pochodnych oksymu - Google Patents

Sposob wytwarzania nowych,eterowych pochodnych oksymu Download PDF

Info

Publication number
PL100614B1
PL100614B1 PL1976188006A PL18800676A PL100614B1 PL 100614 B1 PL100614 B1 PL 100614B1 PL 1976188006 A PL1976188006 A PL 1976188006A PL 18800676 A PL18800676 A PL 18800676A PL 100614 B1 PL100614 B1 PL 100614B1
Authority
PL
Poland
Prior art keywords
compounds
formula
oximum
ateric
derivatives
Prior art date
Application number
PL1976188006A
Other languages
English (en)
Polish (pl)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL100614B1 publication Critical patent/PL100614B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32Oximes
    • C07C251/50Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals
    • C07C251/58Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/04Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
    • C07C249/08Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes by reaction of hydroxylamines with carbonyl compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL1976188006A 1975-03-20 1976-03-17 Sposob wytwarzania nowych,eterowych pochodnych oksymu PL100614B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7503310A NL7503310A (nl) 1975-03-20 1975-03-20 Verbindingen met antidepressieve werking.

Publications (1)

Publication Number Publication Date
PL100614B1 true PL100614B1 (pl) 1978-10-31

Family

ID=19823424

Family Applications (3)

Application Number Title Priority Date Filing Date
PL1976188006A PL100614B1 (pl) 1975-03-20 1976-03-17 Sposob wytwarzania nowych,eterowych pochodnych oksymu
PL1976199557A PL101951B1 (pl) 1975-03-20 1976-03-17 A method of producing new ether derivatives of oxime
PL1976199556A PL100052B1 (pl) 1975-03-20 1976-03-17 Sposob wytwarzania nowych eterowych pochodnych oksymu

Family Applications After (2)

Application Number Title Priority Date Filing Date
PL1976199557A PL101951B1 (pl) 1975-03-20 1976-03-17 A method of producing new ether derivatives of oxime
PL1976199556A PL100052B1 (pl) 1975-03-20 1976-03-17 Sposob wytwarzania nowych eterowych pochodnych oksymu

Country Status (27)

Country Link
US (1) US4085225A (forum.php)
JP (1) JPS6026776B2 (forum.php)
AR (2) AR211011A1 (forum.php)
AT (1) AT340895B (forum.php)
AU (1) AU505358B2 (forum.php)
BE (1) BE839744A (forum.php)
CA (1) CA1076142A (forum.php)
CH (4) CH626057A5 (forum.php)
DD (1) DD128332A5 (forum.php)
DE (1) DE2610886A1 (forum.php)
DK (1) DK144942C (forum.php)
ES (1) ES446192A1 (forum.php)
FI (1) FI61875C (forum.php)
FR (1) FR2304336A1 (forum.php)
GB (1) GB1535226A (forum.php)
GR (1) GR60052B (forum.php)
HU (1) HU171030B (forum.php)
IE (1) IE43768B1 (forum.php)
IL (1) IL49238A (forum.php)
IT (1) IT1063064B (forum.php)
MX (1) MX9203723A (forum.php)
NL (1) NL7503310A (forum.php)
PL (3) PL100614B1 (forum.php)
SE (1) SE410312B (forum.php)
SU (3) SU635867A3 (forum.php)
YU (1) YU39345B (forum.php)
ZA (1) ZA761434B (forum.php)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1110460B (it) * 1977-03-02 1985-12-23 Ciba Geigy Ag Prodotti che favoriscono la crescita delle piante e prodotti che proteggono le piante a base di eteri di ossime e di esteri di ossime loro preparazione e loro impiego
FR2639942B1 (fr) * 1988-12-02 1991-03-29 Sanofi Sa Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
US5665756A (en) * 1994-08-03 1997-09-09 Hoechst Marion Roussel, Inc. Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders
US6548084B2 (en) * 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
ATE192042T1 (de) * 1995-08-16 2000-05-15 Lilly Co Eli Potenzierung von serotonin-wirkstoffresponz
IN182588B (forum.php) 1998-05-12 1999-05-08 Sun Pharmaceutical Ind Ltd
IE990406A1 (en) 1999-05-20 2000-12-27 Elan Corp Plc Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
IN186677B (forum.php) 1999-11-12 2001-10-20 Sun Pharmaceutical Ind Ltd
US20080021085A1 (en) * 2000-04-13 2008-01-24 Mayo Foundation For Medical Education And Research Method of reducing abeta42 and treating diseases
AU5702201A (en) * 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
US7256191B2 (en) * 2000-04-24 2007-08-14 Aryx Therapeutics Materials and methods for the treatment of depression
JP2003531169A (ja) 2000-04-24 2003-10-21 アリックス セラピューティクス うつ病治療のための材料と方法
CN1606554B (zh) * 2001-10-12 2013-03-20 阿泽范药品公司 β-内酰胺后叶加压素V1a拮抗剂
KR20040088519A (ko) 2002-02-22 2004-10-16 뉴 리버 파마슈티칼스, 인크. 활성 제제 전달 시스템 및 활성 제제의 보호 및 투여 방법
EP1603548A4 (en) * 2003-02-05 2007-10-10 Myriad Genetics Inc METHOD AND COMPOSITION FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
EP1651195A4 (en) * 2003-07-11 2007-10-03 Myriad Genetics Inc PHARMACEUTICAL PROCESSES, DOSIERSCHEMATA AND DOSAGE FORMS FOR THE TREATMENT OF ALZHEIMER DISEASE
RU2320369C2 (ru) 2003-09-12 2008-03-27 Пфайзер Инк. Комбинации, содержащие альфа-2-дельта лиганды и ингибиторы обратного захвата серотонина/норадреналина
BRPI0416989A (pt) * 2003-11-26 2007-02-06 Pfizer Prod Inc derivados aminopirazole como inibidores gsk-3
WO2005060968A1 (en) 2003-12-11 2005-07-07 Sepracor Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
EP1737473A4 (en) * 2004-04-19 2009-08-26 Noven Therapeutics Llc COMBINATIONS OF LITHIUM AND USES THEREOF
KR20070004036A (ko) * 2004-04-29 2007-01-05 키스톤 리테이닝 월 시스템스, 아이엔씨 벽, 옹벽 및 그 외 유사한 것을 위한 베니어
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
BRPI0514303A (pt) * 2004-08-11 2008-06-10 Myriad Genetics Inc composição farmacêutica e método para tratar distúrbios neurodegenerativos
EP1868434A4 (en) 2005-03-22 2011-10-26 Azevan Pharmaceuticals Inc BETA-LACTAMYL ALKANIC ACIDS FOR THE TREATMENT OF PREMIERSTRUELLEN FAULTS
WO2006116151A1 (en) 2005-04-22 2006-11-02 Wyeth Benzofuranyl alkanamine derivatives and uses thereof as 5-ht2c agonists
MX2007012883A (es) 2005-04-22 2007-12-10 Wyeth Corp Derivados de dihidrobenzofurano y usos de los mismos.
AR055054A1 (es) * 2005-04-22 2007-08-01 Wyeth Corp Cristales formados de clorhidrato de (((2r)-7-(2,6-diclorofenil)-5-fluoro-2,3- dihidro-1-benzofurano-2-il) metil ) amina
GT200600165A (es) * 2005-04-22 2007-03-14 Derivados dihidrobenzofuranos y usos de los mismos
NZ565683A (en) * 2005-07-08 2011-04-29 Braincells Inc Methods for identifying agents and conditions that modulate neurogenesis in human neural cells
US20070015832A1 (en) * 2005-07-14 2007-01-18 Myriad Genetics, Incorporated Methods of treating overactive bladder and urinary incontinence
WO2007011878A2 (en) * 2005-07-19 2007-01-25 Azevan Pharmaceuticals, Inc. Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
WO2007014124A2 (en) * 2005-07-22 2007-02-01 Myriad Genetics, Inc. High drug load formulations and dosage forms
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
WO2007053596A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
FR2912057B1 (fr) * 2007-02-07 2009-04-17 Sanofi Aventis Sa Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
TW200806300A (en) * 2006-03-24 2008-02-01 Wyeth Corp New therapeutic combinations for the treatment of depression
JP4615470B2 (ja) * 2006-03-29 2011-01-19 卓郎 簑和田 大脳の認知力を用いた疾患治療・予防の方法および医薬
EP2377531A2 (en) 2006-05-09 2011-10-19 Braincells, Inc. Neurogenesis by modulating angiotensin
CA2651862A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
EP2046119A2 (en) * 2006-07-07 2009-04-15 Myriad Genetics, Inc. Treatment of psychiatric disorders
TW200817003A (en) * 2006-07-31 2008-04-16 Sanofi Aventis Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor
BRPI0716604A2 (pt) 2006-09-08 2013-04-09 Braincells Inc combinaÇÕes contendo um derivado de 4-acilaminopiridina
WO2008034032A2 (en) * 2006-09-14 2008-03-20 Azevan Pharmaceuticals, Inc. Beta-lactam cannabinoid receptor modulators
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20080167363A1 (en) * 2006-12-28 2008-07-10 Braincells, Inc Modulation of Neurogenesis By Melatoninergic Agents
CA2675132A1 (en) * 2007-01-11 2008-07-17 Braincells, Inc. Modulation of neurogenesis with use of modafinil
US20110034565A1 (en) 2008-04-18 2011-02-10 University College Dublin, National University Of Ireland, Dublin Psycho-pharmaceuticals
US20100092479A1 (en) * 2008-08-18 2010-04-15 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
SMT201900392T1 (it) 2009-10-23 2019-09-09 Janssen Pharmaceutica Nv Ottaidropirrolo[3,4-c]pirroli disostituiti come modulatori del recettore di orexina
JP5815552B2 (ja) 2009-12-08 2015-11-17 ケース ウェスタン リザーブ ユニバーシティCase Westernreserve University 眼疾患を治療する化合物および方法
PL3351104T3 (pl) 2010-07-01 2021-06-14 Azevan Pharmaceuticals, Inc. Związki do stosowania w leczeniu okresowych zaburzeń wybuchowych
JP2014508187A (ja) 2011-03-17 2014-04-03 ルピン・リミテッド 選択的セロトニン再取り込み阻害薬の放出制御医薬組成物
KR101427221B1 (ko) * 2012-08-29 2014-08-13 주식회사 에스텍파마 플루복사민 자유 염기의 정제방법 및 이를 이용한 고순도 플루복사민 말레이트의 제조방법
IN2013MU01290A (forum.php) 2013-04-03 2015-04-10 Zcl Chemicals Ltd
JP6723930B2 (ja) 2014-02-07 2020-07-15 エムティーエー タモガトット クタトクソポルトク イロダジャ シグマ−1−受容体アゴニスト化合物の新規使用
BR112016022575A2 (pt) 2014-03-28 2017-08-15 Azevan Pharmaceuticals Inc Composições e métodos para o tratamento de doenças neurodegenerativas
KR20230116948A (ko) * 2016-03-10 2023-08-04 얀센 파마슈티카 엔.브이. 오렉신-2 수용체 길항제를 사용한 우울증의 치료 방법
EP3544420B8 (en) 2016-11-24 2022-11-23 Sigmadrugs Kutató Korlátolt Felelösségü Társaság Use of compositions for organ/tissue preservation
CN111295373B (zh) 2017-09-15 2024-12-10 阿泽凡药物公司 用于治疗脑损伤的组合物和方法
KR20220049526A (ko) 2019-07-19 2022-04-21 바이오엑셀 테라퓨틱스 인코포레이티드 비-진정성 덱스메데토미딘 치료 양생법
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3692835A (en) * 1967-04-05 1972-09-19 Jan Van Dijk Pharmacologically active amino-ethyl oximes

Also Published As

Publication number Publication date
AR211153A1 (es) 1977-10-31
US4085225A (en) 1978-04-18
DK144942C (da) 1982-12-06
YU71476A (en) 1982-10-31
SE410312B (sv) 1979-10-08
DK115976A (da) 1976-09-21
HU171030B (hu) 1977-10-28
CA1076142A (en) 1980-04-22
CH629761A5 (de) 1982-05-14
FI61875B (fi) 1982-06-30
SU620206A3 (ru) 1978-08-15
AT340895B (de) 1978-01-10
FR2304336B1 (forum.php) 1979-09-28
AU1214776A (en) 1977-09-22
JPS6026776B2 (ja) 1985-06-25
FR2304336A1 (fr) 1976-10-15
IL49238A (en) 1978-08-31
SE7603341L (sv) 1976-09-21
PL100052B1 (pl) 1978-08-31
CH626057A5 (forum.php) 1981-10-30
ES446192A1 (es) 1977-10-01
YU39345B (en) 1984-10-31
IL49238A0 (en) 1976-05-31
AR211011A1 (es) 1977-10-14
IE43768B1 (en) 1981-05-20
AU505358B2 (en) 1979-11-15
SU635867A3 (ru) 1978-11-30
GR60052B (en) 1978-04-04
SU645559A3 (ru) 1979-01-30
GB1535226A (en) 1978-12-13
ATA195476A (de) 1977-05-15
IE43768L (en) 1976-09-20
CH629184A5 (de) 1982-04-15
DE2610886C2 (forum.php) 1987-09-24
BE839744A (fr) 1976-09-20
JPS51125345A (en) 1976-11-01
DK144942B (da) 1982-07-12
CH629477A5 (de) 1982-04-30
IT1063064B (it) 1985-02-11
DE2610886A1 (de) 1976-10-07
PL101951B1 (pl) 1979-02-28
MX9203723A (es) 1992-07-01
FI61875C (fi) 1982-10-11
ZA761434B (en) 1977-10-26
DD128332A5 (de) 1977-11-09
FI760699A7 (forum.php) 1976-09-21
NL7503310A (nl) 1976-09-22

Similar Documents

Publication Publication Date Title
PL100614B1 (pl) Sposob wytwarzania nowych,eterowych pochodnych oksymu
TWI311990B (en) New compounds with therapeutic effect
JPH01226818A (ja) アリールアミドアザビシクロアルカン類およびアリールチオアミドアザビシクロアルカン類からなる記憶力増進剤または記憶障害治療剤
JPS60228477A (ja) 2‐アルコキシ‐n‐(1‐アザビシクロ[2,2,2]オクト‐3‐イル)ベンズアミド類およびチオベンズアミド類
PT97512B (pt) Processo para a preparacao de derivados de aminas etanobiciclicas, uteis para perturbacoes do snc
AT394552B (de) Verfahren zur herstellung des neuen n-(2-(4-fluor-phenyl)-1-methyl)-aethyl-n-methyl- propinylamin und isomeren und salzen desselben
CN113891873B (zh) 新型培比洛芬盐、其制备方法及包含其的药物组合物
HU197842B (en) Process for producing pharmaceutical compositions comprising 2-alkoxy-n-(1-azabicyclo/2.2.2/oct-3-yl)-benzamide derivatives
US3966936A (en) Piperazino quinazoline bronchodilators
WO2008080290A1 (fr) Antagoniste selectif du recepteur m4 et utilisation medicale associee
FI61182C (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva butylaminderivat
EP0025109B1 (de) 1-Benzoxepin-5(2H)-on-Derivate und ihre Salze sowie Verfahren zu deren Herstellung
PL100617B1 (pl) Sposob wytwarzania nowych eterowych pochodnych oksymu
FI67077B (fi) Analogifoerfarande foer framstaellning av antidepressivt verksamma aralkylamider av aminosyror
JPH03169841A (ja) アミノプロパノール誘導体およびそれを含有する薬剤組成物、ならびにそれらの製造方法
JPS6377882A (ja) 2,3,4,5,6,7−ヘキサヒドロ−2,7−メタノ−1,5−(もしくは−1,4−)ベンゾキサゾニン、その製法及び該化合物を含有する鎮痛剤
AU592358B2 (en) Derivatives of diphenoxyethylamine, a process for their production and the pharmaceutical compositions containing the same
HU178147B (en) Process for producing hexahydro-1,4-oxazepines
KR0146340B1 (ko) (+)1-(3,4,5-트리메톡시)벤질옥시메틸-1-페닐-n,n-디메틸-n-프로필아민, 이의제조방법 및 치료학적용도
HU192876B (en) Process for producing 5,10-dihydro-11h-dibenzo/b,e//1,4/ diazepin-11-one derivatives substitutes at the 5 position and pharmaceutical compositions containing them
US4605673A (en) 7H-dibenzo(a,c,)cyclohepten-5-one-(7) derivatives
JP4530853B2 (ja) 抗コレシストキニン活性(抗−cck−1)を有するアントラニル酸誘導体、その製造法および医薬用途
JPH0154326B2 (forum.php)
PL100048B1 (pl) Sposob wytwarzania nowych,eterowych pochodnych oksymu
US3903165A (en) Ethynylaryl amines and processes for their preparation